Show simple item record

dc.contributor.authorFerenci, P.
dc.contributor.authorSimon, K.
dc.contributor.authorCakaloglu, Y.
dc.contributor.authorOrmeci, N.
dc.contributor.authorGigi, M. Raptopoulou
dc.contributor.authorJanssen, H. L. A.
dc.contributor.authorRijckborst, V.
dc.contributor.authorAkdogan, M.
dc.contributor.authorTabak, F.
dc.contributor.authorHansen, B. E.
dc.contributor.authorter Borg, M. J.
dc.contributor.authorvan Vuuren, A. J.
dc.contributor.authorVerhey, E.
dc.contributor.authorvan Doornum, G. J. J.
dc.contributor.authorZondervan, P. E.
dc.date.accessioned2021-03-04T11:00:36Z
dc.date.available2021-03-04T11:00:36Z
dc.date.issued2009
dc.identifier.citationJanssen H. L. A. , Rijckborst V., Cakaloglu Y., Ferenci P., Tabak F., Akdogan M., Simon K., Gigi M. R. , Ormeci N., Zondervan P. E. , et al., "48 weeks of peginterferon alpha-2a alone or in combination with ribavirin for HBeAg-negative chronic hepatitis B: addition of ribavirin does not increase response rates", EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.21, sa.3, 2009
dc.identifier.issn0954-691X
dc.identifier.otherav_7021a03a-01b8-4b58-947d-3829fc9d0aa9
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/77313
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectKlinik Tıp
dc.title48 weeks of peginterferon alpha-2a alone or in combination with ribavirin for HBeAg-negative chronic hepatitis B: addition of ribavirin does not increase response rates
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
dc.contributor.departmentErasmus University Rotterdam , ,
dc.identifier.volume21
dc.identifier.issue3
dc.contributor.firstauthorID191856


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record